Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

BUY
$101.21 - $166.61 $406,155 - $668,605
4,013 New
4,013 $524,000
Q4 2023

Jan 29, 2024

SELL
$69.51 - $104.43 $792,414 - $1.19 Million
-11,400 Reduced 72.09%
4,413 $394,000
Q3 2023

Oct 12, 2023

BUY
$96.41 - $126.61 $1.52 Million - $2 Million
15,813 New
15,813 $1.76 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Granite Bay Wealth Management, LLC Portfolio

Follow Granite Bay Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Bay Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Bay Wealth Management, LLC with notifications on news.